drugset / Trial / NCT02772497
3 Month Outcome of Ziv-aflibercept for DME
NaSingle-groupOpen-labelTreatment
Summary
The purpose is to show the 3-month efficacy and safety in diabetic macular edema treated with intravitreal ziv-aflibercept.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-05
- Completion
- 2016-05
Publications
- Results Marashi A (2016) Three-Month Outcome of Ziv-Aflibercept for Diabetic Macular Edema. Adv Ophthalmol Vis Syst 4(3): 00114. DOI: 10.15406/aovs.2016.04.00114
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | 1.25 mg | Intravitreal |